Innate Pharma S.A.
IPHA
$2.07
$0.041.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.66% | -22.41% | -7.17% | -8.41% | -0.69% |
| Total Receivables | 8.66% | -23.50% | -7.18% | -87.63% | -0.69% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.65% | -20.37% | -7.17% | -2.44% | -0.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.66% | 227.32% | -7.17% | -82.08% | -0.69% |
| Total Current Assets | 8.66% | -20.88% | -7.17% | -20.02% | -0.69% |
|
|
|||||
| Total Current Assets | 8.66% | -20.88% | -7.17% | -20.02% | -0.69% |
| Net Property, Plant & Equipment | 8.65% | 0.78% | -7.18% | -7.04% | -0.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -0.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.66% | 32.98% | -7.18% | -56.48% | -0.69% |
| Total Assets | 8.66% | -12.64% | -7.17% | -23.69% | -0.69% |
|
|
|||||
| Total Accounts Payable | 8.66% | -40.03% | -7.17% | -5.76% | -0.69% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.66% | 7.10% | -7.17% | 1.53% | -0.69% |
| Total Finance Division Other Current Liabilities | 8.66% | 1.79% | -7.17% | -17.16% | -0.69% |
| Total Other Current Liabilities | 8.66% | 1.79% | -7.17% | -17.16% | -0.69% |
| Total Current Liabilities | 8.66% | -6.86% | -7.17% | -10.18% | -0.69% |
|
|
|||||
| Total Current Liabilities | 8.66% | -6.86% | -7.17% | -10.18% | -0.69% |
| Long-Term Debt | 8.66% | -15.55% | -7.17% | -12.57% | -0.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.64% | 51.53% | -7.16% | -33.98% | -0.68% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.66% | -10.46% | -7.17% | -15.58% | -0.69% |
| Total Liabilities | 8.66% | -10.34% | -7.17% | -13.28% | -0.69% |
|
|
|||||
| Common Stock & APIC | 8.66% | 8.75% | -7.17% | 5.45% | -0.69% |
| Retained Earnings | -8.66% | -10.17% | 7.17% | -11.20% | 0.69% |
| Treasury Stock & Other | 8.66% | 4,508.93% | -6.98% | -92.09% | -0.68% |
| Total Common Equity | 8.65% | -39.21% | -7.17% | -68.07% | -0.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.65% | -39.21% | -7.17% | -68.07% | -0.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.65% | -39.21% | -7.17% | -68.07% | -0.69% |
|
|
|||||